Pharmacokinetic Properties of Fast-Acting Insulin Aspart Administered in Different Subcutaneous Injection Regions
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1918
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Pharmacokinetic Properties of Fast-Acting Insulin Aspart Administered in Different Subcutaneous Injection Regions ; day:10 ; month:2 ; year:2017 ; pages:1-7
Clinical drug investigation ; (10.2.2017), 1-7
- Schlagwort
-
Biopharmazie
Pharmakodynamik
Pharmakokinetik
- Urheber
-
Hövelmann, Ulrike
- Beteiligte Personen und Organisationen
-
Heise, Tim
Nosek, Leszek
Sassenfeld, Bettina
Thomsen, Karen Margrete Due
Haahr, Hanne
SpringerLink (Online service)
- DOI
-
10.1007/s40261-017-0499-y
- URN
-
urn:nbn:de:1111-2017030516346
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hövelmann, Ulrike
- Heise, Tim
- Nosek, Leszek
- Sassenfeld, Bettina
- Thomsen, Karen Margrete Due
- Haahr, Hanne
- SpringerLink (Online service)
Ähnliche Objekte (12)
Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling
Bioavailability of IgG Administered by the Subcutaneous Route
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
Glyco-engineered Long Acting FGF21 Variant with Optimal Pharmaceutical and Pharmacokinetic Properties to Enable Weekly to Twice Monthly Subcutaneous Dosing
Correction to: Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling
Design Development of the SMARTCLIC®/CLICWISE® Injection Device for Self-Administered Subcutaneous Therapies: Findings from Usability and Human Factor Studies
Fluazuron orally administered to guinea pigs: pharmacokinetic and efficacy against Amblyomma sculptum
Absorption of Different Salts of Heparin Following Subcutaneous Injection
Embolia Cutis Medicamentosa after Subcutaneous Injection with Glatiramer Acetate
Population Pharmacokinetic Modeling and Simulation for Dose Optimization of GB-5001, a Long-Acting Intramuscular Injection of Donepezil, in Healthy Participants
Estimation of tulathromycin depletion in plasma and milk after subcutaneous injection in lactating goats using a nonlinear mixed-effects pharmacokinetic modeling approach
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling
Bioavailability of IgG Administered by the Subcutaneous Route
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
Glyco-engineered Long Acting FGF21 Variant with Optimal Pharmaceutical and Pharmacokinetic Properties to Enable Weekly to Twice Monthly Subcutaneous Dosing
Correction to: Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling
Design Development of the SMARTCLIC®/CLICWISE® Injection Device for Self-Administered Subcutaneous Therapies: Findings from Usability and Human Factor Studies
Fluazuron orally administered to guinea pigs: pharmacokinetic and efficacy against Amblyomma sculptum
Absorption of Different Salts of Heparin Following Subcutaneous Injection
Embolia Cutis Medicamentosa after Subcutaneous Injection with Glatiramer Acetate
Population Pharmacokinetic Modeling and Simulation for Dose Optimization of GB-5001, a Long-Acting Intramuscular Injection of Donepezil, in Healthy Participants
Estimation of tulathromycin depletion in plasma and milk after subcutaneous injection in lactating goats using a nonlinear mixed-effects pharmacokinetic modeling approach
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling
Bioavailability of IgG Administered by the Subcutaneous Route
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
Glyco-engineered Long Acting FGF21 Variant with Optimal Pharmaceutical and Pharmacokinetic Properties to Enable Weekly to Twice Monthly Subcutaneous Dosing
Correction to: Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling
Design Development of the SMARTCLIC®/CLICWISE® Injection Device for Self-Administered Subcutaneous Therapies: Findings from Usability and Human Factor Studies
Fluazuron orally administered to guinea pigs: pharmacokinetic and efficacy against Amblyomma sculptum
Absorption of Different Salts of Heparin Following Subcutaneous Injection
Embolia Cutis Medicamentosa after Subcutaneous Injection with Glatiramer Acetate
Population Pharmacokinetic Modeling and Simulation for Dose Optimization of GB-5001, a Long-Acting Intramuscular Injection of Donepezil, in Healthy Participants
Estimation of tulathromycin depletion in plasma and milk after subcutaneous injection in lactating goats using a nonlinear mixed-effects pharmacokinetic modeling approach